Cargando…
Adjunctive treatment with moxonidine versus nitrendipine for hypertensive patients with advanced renal failure: a cost-effectiveness analysis
BACKGROUND: Systemic hypertension often accompanies chronic renal failure and can accelerate its progression to end-stage renal disease (ESRD). Adjunctive moxonidine appeared to have benefits versus adjunctive nitrendipine, in a randomised double-blind six-month trial in hypertensive patients with a...
Autores principales: | Littlewood, Kavi J, Greiner, Wolfgang, Baum, Dominique, Zoellner, York |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976090/ https://www.ncbi.nlm.nih.gov/pubmed/17645811 http://dx.doi.org/10.1186/1471-2369-8-9 |
Ejemplares similares
-
Cost-effectiveness of nitrendipine and hydrochlorothiazide or metoprolol to treat hypertension in rural community health centers in China
por: Wang, Zengwu, et al.
Publicado: (2017) -
Formulation and Evaluation of Nitrendipine Buccal Films
por: Nappinnai, M., et al.
Publicado: (2008) -
Nitrendipine and Dementia: Forgotten Positive Facts?
por: Novotny, Michal, et al.
Publicado: (2018) -
Development of Hydrophilic Interaction Liquid Chromatography Method for the Analysis of Moxonidine and Its Impurities
por: Filipic, Slavica, et al.
Publicado: (2016) -
Improved Hypertension Control with the Imidazoline Agonist Moxonidine in a Multinational Metabolic Syndrome Population: Principal Results of the MERSY Study
por: Chazova, Irina, et al.
Publicado: (2013)